Product Information
NEURONTIN 300 MG CAPSULE is a brand product labeled by Pfizer Inc., priced at $7.3865 per EA under NDC 00071080524. Its NADAC has been published 652 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Pfizer Inc.NDC
00071080524
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
GABAPENTINApproval Type
New Drug (NDA)
FDA Application
NDA020235On Market Since
12/30/1993
Pharmacological Classes
Price Statistics
The NADAC for NEURONTIN 300 MG CAPSULE has been published 652 times since Nov 28, 2013, and over the history we have for it it has risen 209.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.3865 per EA |
|---|---|
| All-time high | $7.3865 (Jun 24, 2026) |
| All-time low | $2.3853 (Nov 28, 2013) |
| 52-week high | $7.3865 |
| 52-week low | $7.0348 |
| Median price | $5.6179 |
| Average price | $5.2525 |
| Largest weekly change | +13.0% (Jan 7, 2015) |
| Weeks tracked | 652 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NEURONTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NEURONTIN 300 MG CAPSULE, manufactured by Pfizer Inc., is $7.3865 per EA (NDC 00071080524), effective Jun 24, 2026.
How has the price of NEURONTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NEURONTIN 300 MG CAPSULE has risen 209.7%. It has been tracked across 652 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEURONTIN 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for NEURONTIN 300 MG CAPSULE has ranged from a low of $2.3853 (Nov 28, 2013) to a high of $7.3865 (Jun 24, 2026), with a median of $5.6179 per EA.
Are there cheaper alternatives to NEURONTIN 300 MG CAPSULE?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GABAPENTIN 300 MG CAPSULE, is $0.0324 per EA — about 100% below NEURONTIN 300 MG CAPSULE.
Who manufactures NEURONTIN 300 MG CAPSULE?
NEURONTIN 300 MG CAPSULE (NDC 00071080524) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification